Abstract
This research service covers the strategic analysis of the U.S.
biopharmaceutical market 2004-2014. Included are technology trends, total
market revenue forecasts, and selected market segment revenue forecasts. The
market is segmented by product class: antisense, cytokines and proteins,
enzymes and hormones, gene and cell therapies, and vaccines. Major market
challenges, drivers, and restraints and identified and discussed. Also
included is selected late stage pipeline analysis.
| 
View Cart
